Clinical Study

R1008- A Randomized Phase II Study Of Adjuvant Concurrent Radiation And Chemotherapy Versus Radiation Alone In Resected High-Risk Malignant Salivary Gland Tumors

Posted Date: May 15, 2019

  • Investigator: Jordan Kharofa
  • Specialties: Cancer, Head and Neck Cancer, Oncology
  • Type of Study: Drug

This study will compare the good and bad effects of radiation and chemotherapy with radiation alone on salivary gland cancer to find out which is better at reducing the chance of the cancer returning.


To Be Eligible: Must Have Cancer Of The Salivary Gland That Has Been Removed By Surgery, Age 18 Or Older, Nonpregnant, No Prior Invasive Malignancy In 3 Years.


Head And Neck Cancer, Salivary Gland, Radiation, Rtog 1008, Salivary Gland

For More Information:

Uc Cancer Institute

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.